Confidence-driven, agile protection: WuXi AppTec (02359) initiates a ten billion yuan A-share buyback, balancing market value maintenance and long-term incentive.

Facing the sudden external turbulence, WuXi AppTec (02359, 603259.SH) chose to respond with "real gold and silver" in the most direct and agile manner. On the day it was listed on the US Department of Defense's 1260H list, this leading CXO enterprise swiftly released a report and announced plans to use 1 billion yuan of its own funds to repurchase company A-shares through centralized bidding. From external pressure to decisive response, WuXi AppTec not only calmed the market sentiment with swift action, but also conveyed the management's firm defense and confidence in the company's long-term value to the outside world. The devil is in the details. Behind the repurchase limit of up to 156.95 yuan per share and the estimated repurchase volume of about 6.37 million shares, is WuXi AppTec's strategic consideration of the "positive sum game", clearly stating that the repurchased shares will be used for an employee stock ownership plan. Thanks to the authorization from the previous shareholders' meeting, the company was able to quickly implement the plan within the rules, stabilizing market position with high execution capability. The more profound significance lies in the fact that this move, by improving long-term incentive mechanisms, closely intertwines the interests of the core team with the company and shareholders, cleverly achieving a deep integration of "short-term stability of expectations" and "long-term promotion of development". The confidence behind the firm's agile protection strategy comes from WuXi AppTec's continuously "bursting" performance fundamentals and ample cash flow. In 2025, the company achieved annual operating income of 45.456 billion yuan, with a net profit attributable to shareholders increasing by 102.65% to 19.151 billion yuan, and the annual adjusted operating cash flow reaching a historic high of 16.67 billion yuan. Entering 2026, the strong momentum continued, with the company achieving first quarter revenue of 12.4 billion yuan, setting a new high for the same period in history; the continuous operating business backlog orders also rose to a historical high of nearly 60 billion yuan. The strong self-generating ability and high visibility of performance give the company sufficient confidence to maintain high capital expenditure while calmly implementing large-scale share repurchases. Indeed, this 1 billion yuan A-share repurchase is not an isolated event, but the latest step in WuXi AppTec's creation of a long-term "value loop". Since its listing in 2018, the company has returned nearly 25 billion yuan to investors through cash dividends and share repurchases. Just at the end of May, the company implemented a record-breaking cash dividend of over 4.7 billion yuan and simultaneously launched an H-share bonus trust plan worth 2.5 billion Hong Kong dollars. In a key stage where the pharmaceutical outsourcing industry is experiencing "differentiation", WuXi AppTec is conveying a high level of certainty to the market with the strategy of "confidence-driven, agile protection". In the future, WuXi AppTec will continue to focus on its core CRDMO strategy, drive governance through capital return and organizational vitality, build sustained growth certainty in a volatile market, continuously consolidate its position as the leading global pharmaceutical R&D infrastructure, and create long-term value for investors beyond the cycle.